| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1918761 | Maturitas | 2007 | 4 Pages |
Abstract
There are good reasons why the use of postmenopausal hormone therapy is at a contemporary low level. But an analysis of these factors provides explanations that offer a basis for appropriate and renewed use. A more optimistic position is supported by an up-to-date appraisal of clinical studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Leon Speroff,